MNKD Q4 2019 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena

MNKDMannKind Corporation

$841M

Q4 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$16M-0.2% YoY

Gross Profit

$9M56.1% margin

Operating Income

-$11M-71.0% margin

Net Income

-$14M-89.2% margin

EPS (Diluted)

$-0.07

QoQ Revenue Growth

+9.6%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$891,000

Balance Sheet

Total Assets

$94M

Total Liabilities

$284M

Stockholders' Equity

-$191M

Cash & Equivalents

$30M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$16M	$16M	-0.2%
Gross Profit	$9M	$10M	-9.9%
Operating Income	-$11M	-$8M	-46.9%
Net Income	-$14M	-$10M	-46.3%

Revenue Segments

License And Service

$2M100%